← Browse by Condition
Medical Condition
merkel cell carcinoma
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 2
NCT06047379 Phase 1, Phase 2
Recruiting
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Enrollment
134 pts
Location
United States
Sponsor
Neonc Technologies, Inc.
NCT05076760 Phase 1
Recruiting
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
Enrollment
40 pts
Location
United States
Sponsor
Memgen, Inc.
NCT06223659 Phase 2
Recruiting
EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
Enrollment
100 pts
Location
United States
Sponsor
Ohio State University Comprehe...
NCT04349436 Phase 1, Phase 2
Recruiting
Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies
Enrollment
90 pts
Location
United States
Sponsor
Replimune Inc.